Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tranexamic Acid for Prevention of Subconjunctival Hemorrhage After Intravitreal Injections
NCT04400916Unknown
- Sponsor
- Rambam Health Care Campus
- Start
- Sep 2020
- Primary completion
- Sep 2021
- Modality
- Small Molecules
01
Overview
Trial of tranexamic acid in subconjunctival hemorrhage (SCH) (2 arms), sponsored by Rambam Health Care Campus. Primary endpoint: Occurrence of subconjunctival hemorrhage at 3 days. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
subconjunctival hemorrhage (SCH)
Beyond the preview
Go deeper on NCT04400916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04400916.